Brief: Enorama Pharma Subsidiary Intends To Appeal FDA's Refuse-To-File Decision
03/02/2026 09:33
Feb 3 (Reuters) - Enorama Pharma AB ERMA.ST: SUBSIDIARY INTENDS TO APPEAL FDA'S RTF DECISION COMPANY IN CONTACT WITH FDA FOR CLARITY ON REGULATORY STATUS ANALYZING FDA DECISION AND EVALUATING CONSEQUENCES Source text: ID:nWkr548YTx Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO